A recent study has found that colonoscopy surveillance in patients with inflammatory bowel disease effectively reduces the risk of colorectal cancer, according to a report by The Oncology Report.
The researchers found that colonoscopy screening IBD patients within the previous three years reduced the odds of colorectal cancer development by 35 percent. Screening also reduced the risk of death if cancer does develop by 50 percent.
The results of the study serve to support previously unsupported guidelines on colonoscopy surveillance in IBD.
More articles on gastroenterology:
Does capnography add benefit to colonoscopy?
Improving access to specialty care in GI: 7 things to know
5 gastroenterologists making the news
The researchers found that colonoscopy screening IBD patients within the previous three years reduced the odds of colorectal cancer development by 35 percent. Screening also reduced the risk of death if cancer does develop by 50 percent.
The results of the study serve to support previously unsupported guidelines on colonoscopy surveillance in IBD.
More articles on gastroenterology:
Does capnography add benefit to colonoscopy?
Improving access to specialty care in GI: 7 things to know
5 gastroenterologists making the news